Literature DB >> 18794854

MYH9 is associated with nondiabetic end-stage renal disease in African Americans.

W H Linda Kao1, Michael J Klag, Lucy A Meoni, David Reich, Yvette Berthier-Schaad, Man Li, Josef Coresh, Nick Patterson, Arti Tandon, Neil R Powe, Nancy E Fink, John H Sadler, Matthew R Weir, Hanna E Abboud, Sharon G Adler, Jasmin Divers, Sudha K Iyengar, Barry I Freedman, Paul L Kimmel, William C Knowler, Orly F Kohn, Kristopher Kramp, David J Leehey, Susanne B Nicholas, Madeleine V Pahl, Jeffrey R Schelling, John R Sedor, Denyse Thornley-Brown, Cheryl A Winkler, Michael W Smith, Rulan S Parekh.   

Abstract

As end-stage renal disease (ESRD) has a four times higher incidence in African Americans compared to European Americans, we hypothesized that susceptibility alleles for ESRD have a higher frequency in the West African than the European gene pool. We carried out a genome-wide admixture scan in 1,372 ESRD cases and 806 controls and found a highly significant association between excess African ancestry and nondiabetic ESRD (lod score = 5.70) but not diabetic ESRD (lod = 0.47) on chromosome 22q12. Each copy of the European ancestral allele conferred a relative risk of 0.50 (95% CI = 0.39-0.63) compared to African ancestry. Multiple common SNPs (allele frequencies ranging from 0.2 to 0.6) in the gene encoding nonmuscle myosin heavy chain type II isoform A (MYH9) were associated with two to four times greater risk of nondiabetic ESRD and accounted for a large proportion of the excess risk of ESRD observed in African compared to European Americans.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18794854      PMCID: PMC2614692          DOI: 10.1038/ng.232

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  33 in total

1.  Mapping of a gene for May-Hegglin anomaly to chromosome 22q.

Authors:  S Kunishima; T Kojima; T Tanaka; T Kamiya; K Ozawa; Y Nakamura; H Saito
Journal:  Hum Genet       Date:  1999-11       Impact factor: 4.132

2.  Estimation of admixture and detection of linkage in admixed populations by a Bayesian approach: application to African-American populations.

Authors:  P M McKeigue; J R Carpenter; E J Parra; M D Shriver
Journal:  Ann Hum Genet       Date:  2000-03       Impact factor: 1.670

3.  Excess risk of chronic kidney disease among African-American versus white subjects in the United States: a population-based study of potential explanatory factors.

Authors:  Michelle E Tarver-Carr; Neil R Powe; Mark S Eberhardt; Thomas A LaVeist; Raynard S Kington; Josef Coresh; Frederick L Brancati
Journal:  J Am Soc Nephrol       Date:  2002-09       Impact factor: 10.121

4.  MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis.

Authors:  Jeffrey B Kopp; Michael W Smith; George W Nelson; Randall C Johnson; Barry I Freedman; Donald W Bowden; Taras Oleksyk; Louise M McKenzie; Hiroshi Kajiyama; Tejinder S Ahuja; Jeffrey S Berns; William Briggs; Monique E Cho; Richard A Dart; Paul L Kimmel; Stephen M Korbet; Donna M Michel; Michele H Mokrzycki; Jeffrey R Schelling; Eric Simon; Howard Trachtman; David Vlahov; Cheryl A Winkler
Journal:  Nat Genet       Date:  2008-09-14       Impact factor: 38.330

5.  Large-scale analysis of the human and mouse transcriptomes.

Authors:  Andrew I Su; Michael P Cooke; Keith A Ching; Yaron Hakak; John R Walker; Tim Wiltshire; Anthony P Orth; Raquel G Vega; Lisa M Sapinoso; Aziz Moqrich; Ardem Patapoutian; Garret M Hampton; Peter G Schultz; John B Hogenesch
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

6.  Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial.

Authors:  Jackson T Wright; George Bakris; Tom Greene; Larry Y Agodoa; Lawrence J Appel; Jeanne Charleston; DeAnna Cheek; Janice G Douglas-Baltimore; Jennifer Gassman; Richard Glassock; Lee Hebert; Kenneth Jamerson; Julia Lewis; Robert A Phillips; Robert D Toto; John P Middleton; Stephen G Rostand
Journal:  JAMA       Date:  2002-11-20       Impact factor: 56.272

7.  Mutation of MYH9, encoding non-muscle myosin heavy chain A, in May-Hegglin anomaly.

Authors:  M J Kelley; W Jawien; T L Ortel; J F Korczak
Journal:  Nat Genet       Date:  2000-09       Impact factor: 38.330

8.  Linkage analysis of candidate loci for end-stage renal disease due to diabetic nephropathy.

Authors:  Sudha K Iyengar; Katherine A Fox; Marlene Schachere; Fauzia Manzoor; Mary E Slaughter; Adrian M Covic; S Mohammed Orloff; Patrick S Hayden; Jane M Olson; Jeffrey R Schelling; John R Sedor
Journal:  J Am Soc Nephrol       Date:  2003-07       Impact factor: 10.121

9.  Epstein syndrome: another renal disorder with mutations in the nonmuscle myosin heavy chain 9 gene.

Authors:  Marco Seri; Maria Savino; Domenico Bordo; Roberto Cusano; Bianca Rocca; Ilaria Meloni; Filomena Di Bari; Pasi A Koivisto; Martino Bolognesi; Gian Marco Ghiggeri; Raffaele Landolfi; Carlo L Balduini; Leopoldo Zelante; Roberto Ravazzolo; Alessandra Renieri; Anna Savoia
Journal:  Hum Genet       Date:  2001-12-14       Impact factor: 4.132

10.  Cloning of the murine non-muscle myosin heavy chain IIA gene ortholog of human MYH9 responsible for May-Hegglin, Sebastian, Fechtner, and Epstein syndromes.

Authors:  Maria D'Apolito; Vito Guarnieri; Marianna Boncristiano; Leopoldo Zelante; Anna Savoia
Journal:  Gene       Date:  2002-03-20       Impact factor: 3.688

View more
  354 in total

1.  Hypertensive renal injury is associated with gene variation affecting immune signaling.

Authors:  Michael C Braun; Stacy M Herring; Nisha Gokul; Monique Monita; Rebecca Bell; Yaming Zhu; Manuel L Gonzalez-Garay; Scott E Wenderfer; Peter A Doris
Journal:  Circ Cardiovasc Genet       Date:  2014-11-03

2.  Advances in our understanding of the pathogenesis of HIV-1 associated nephropathy in children.

Authors:  Patricio E Ray; Chien-An A Hu
Journal:  Future Virol       Date:  2011-07       Impact factor: 1.831

Review 3.  Genome-wide association studies of chronic kidney disease: what have we learned?

Authors:  Conall M O'Seaghdha; Caroline S Fox
Journal:  Nat Rev Nephrol       Date:  2011-12-06       Impact factor: 28.314

4.  Racial differences in postprandial mineral ion handling in health and in chronic kidney disease.

Authors:  Orlando M Gutiérrez; Tamara Isakova; Kelsey Smith; Michael Epstein; Neha Patel; Myles Wolf
Journal:  Nephrol Dial Transplant       Date:  2010-06-07       Impact factor: 5.992

5.  Candidate genes for non-diabetic ESRD in African Americans: a genome-wide association study using pooled DNA.

Authors:  Meredith A Bostrom; Lingyi Lu; Jeff Chou; Pamela J Hicks; Jianzhao Xu; Carl D Langefeld; Donald W Bowden; Barry I Freedman
Journal:  Hum Genet       Date:  2010-06-08       Impact factor: 4.132

6.  APOL1 variants change C-terminal conformational dynamics and binding to SNARE protein VAMP8.

Authors:  Sethu M Madhavan; John F O'Toole; Martha Konieczkowski; Laura Barisoni; David B Thomas; Santhi Ganesan; Leslie A Bruggeman; Matthias Buck; John R Sedor
Journal:  JCI Insight       Date:  2017-07-20

7.  Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans.

Authors:  Barry I Freedman; Pamela J Hicks; Meredith A Bostrom; Mary E Cunningham; Yongmei Liu; Jasmin Divers; Jeffrey B Kopp; Cheryl A Winkler; George W Nelson; Carl D Langefeld; Donald W Bowden
Journal:  Kidney Int       Date:  2009-01-28       Impact factor: 10.612

Review 8.  Genetic causes of proteinuria and nephrotic syndrome: impact on podocyte pathobiology.

Authors:  Oleh Akchurin; Kimberly J Reidy
Journal:  Pediatr Nephrol       Date:  2014-03-02       Impact factor: 3.714

9.  Perceptions regarding genetic testing in populations at risk for nephropathy.

Authors:  Barry I Freedman; Alison J Fletcher; Vivek R Sanghani; Mitzie Spainhour; Angelina W Graham; Gregory B Russell; Jessica N Cooke Bailey; Ana S Iltis; Nancy M P King
Journal:  Am J Nephrol       Date:  2013-11-21       Impact factor: 3.754

10.  Kidney disease in the setting of HIV infection: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Authors:  Charles R Swanepoel; Mohamed G Atta; Vivette D D'Agati; Michelle M Estrella; Agnes B Fogo; Saraladevi Naicker; Frank A Post; Nicola Wearne; Cheryl A Winkler; Michael Cheung; David C Wheeler; Wolfgang C Winkelmayer; Christina M Wyatt
Journal:  Kidney Int       Date:  2018-02-03       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.